Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Stomach Neoplasms 1Hyperphagia 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Fanconi Anemia 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Body Weight 1

Interventions

Cisplatin 11pembrolizumab 10Carboplatin 7Radiotherapy 6Cetuximab 6Docetaxel 5Surveys and Questionnaires 3Radiotherapy, Intensity-Modulated 3Paclitaxel 3Cyclophosphamide 3fludarabine 2cemiplimab 2atezolizumab 2aldesleukin 2Surgical Procedures, Operative 2Standard of Care 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Fluorouracil 2Drug Therapy 2vistusertib 1toripalimab 1sitravatinib 1palbociclib 1osimertinib 1olaparib 1niraparib 1lenvatinib 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Dietary Supplements × 90 days × Clear all
NCT03476330 2026-04-20

Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
48 enrolled 7 charts
Classical hematology

Carcinoma, Squamous Cell, Fanconi Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡